Biodesix Announces Two Presentations on Lung Cancer Treatment Guidance Tests at the IASLC 2023 World Lung Conference on Lung Cancer
New data highlights two novel proteomic tests that support treatment decision making in patients with non-small cell lung cancer : Expanded analysis of the VeriStrat® host immune classifier’s...
Wallace Akerley Langone Health Lung Cancer Disease Center Research For Cardiothoracic Surgery Perlmutter Cancer Institute Biodesix Inc
Source: marketscreener.com